Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 7 Issue: 6, September

Nuclear Imaging of Hormonal Receptor Status in Breast Cancer: A Tool for Guiding Endocrine Treatment and Drug Development

Volume:7   Issue: 6
Pp: 510-519
E.F. J. de Vries, M. G. Rots and G.A. P. Hospers
DOI: 10.2174/156800907781662301
Published on: 01 March, 2012

Energetics of Quadruplex-Drug Recognition in Anticancer Therapy

Volume:7   Issue: 6
Pp: 520-540
B. Pagano and C. Giancola
DOI: 10.2174/156800907781662257
Published on: 01 March, 2012

Myelodysplastic Syndromes: Review of Pathophysiology and Current Novel Treatment Approaches

Volume:7   Issue: 6
Pp: 541-558
E. D. Warlick and B. D. Smith
DOI: 10.2174/156800907781662284
Published on: 01 March, 2012

Targeting Microtubules to Inhibit Angiogenesis and Disrupt Tumour Vasculature:Implications for Cancer Treatment

Volume:7   Issue: 6
Pp: 566-581
Eddy Pasquier, Nicolas Andre and Diane Braguer
DOI: 10.2174/156800907781662266
Published on: 01 March, 2012

Stem Cells, Cancer, Liver, and Liver Cancer Stem Cells: Finding a Way Out of the Labyrinth...

Volume:7   Issue: 6
Pp: 582-590
A. C. Piscaglia, T. D. Shupe, B. E. Petersen and A. Gasbarrini
DOI: 10.2174/156800907781662293
Published on: 01 March, 2012

Cross-Talk Between the Androgen Receptor and the Phosphatidylinositol 3-Kinase/Akt Pathway in Prostate Cancer

Volume:7   Issue: 6
Pp: 591-604
Yu Wang, Jeffrey I. Kreisberg and Paramita M. Ghosh
DOI: 10.2174/156800907781662248
Published on: 01 March, 2012